Clinical trials
Neoplasms clinical trials
Below are recruiting neoplasms clinical trials, each written for real people, not researchers. We’re tracking 1,691 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07467824Recruiting
Exercise and support before and after breast cancer treatment
This trial tests whether a program of supervised exercise and full follow-up before and after breast cancer treatment can improve recovery and quality of life for women with early-stage breast cancer.
Valladolid, ValladolidAges 18–65 - NCT07470008Recruiting
Registry study for histotripsy in adults with soft tissue tumors
This study is a registry for adults getting histotripsy—a non-invasive ultrasound that breaks down soft tissue tumors—at UCSF. Joining means researchers can follow your treatment and outcomes to learn more about how well histotripsy works.
San Francisco, CaliforniaAges 18 years+ - NCT07472803Recruiting
Body composition study in early breast cancer patients
This study looks at how body composition (muscle and fat) changes over time in people with early-stage breast cancer. It aims to better understand the effects of cancer treatment on the body.
New Taipei City, Xindian DistAges 18 years+ - NCT07473687Recruiting
Monitoring vital signs without touching in the operating room
This study uses a camera to monitor your heart rate, breathing, and oxygen levels without any sensors touching your skin. It may help make surgery safer and more comfortable.
TaipeiAges 18 years+ - NCT07481851Recruiting
Can skin sensor predict blood pressure drop during spinal anesthesia?
This study tests whether a simple skin sensor can predict a dangerous drop in blood pressure during spinal anesthesia for older adults having urologic cancer surgery. If it works, doctors could take steps to prevent dizziness or fainting.
Ankara, YenimahalleAges 65 years+ - NCT07485855RecruitingPhase 3
Flu vaccine study for blood cancer patients
This trial tests how well the flu vaccine works in people with blood cancers like lymphoma, leukemia, or multiple myeloma. It aims to find the best vaccination strategy to protect you during treatment.
SeoulAges 19 years+ - NCT03510208RecruitingPhase 1/Phase 2
Uses a dye drug during brain or nerve tumor surgery
This trial tests whether a medicine with a fluorescent dye (panitumumab-IRDye800) helps doctors better see certain tumors during surgery. It may help safer, more complete tumor removal for people with glioblastoma or vestibular schwannoma.
Palo Alto, CaliforniaAges 18 years+ - NCT06940648Enrolling by invitation
Bladder lesion removal with a new surgical tool
This trial tests a new tool to remove bladder lesions through the urethra. If you have a small bladder lesion that needs to be removed, this study may be an option.
Hong Kong, Hong KongAges 22 years+ - NCT07487883Recruiting
PET scan for lung cancer using a special tracer
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07491536Recruiting
Ozone therapy for mouth sores from cancer treatment
This trial tests if adding ozone therapy to a special mouthwash routine can help heal painful mouth sores caused by chemotherapy or radiation. It is for cancer patients with mild to moderate oral mucositis.
Pavia, LombardyAges 18 years+ - NCT07495072Recruiting
Timing of Blad-Care during BCG therapy for bladder cancer
This trial tests whether giving Blad-Care early or later during BCG treatment changes outcomes for people with non-muscle-invasive bladder cancer. BCG is a standard therapy that uses a germ to help your immune system fight cancer, and Blad-Care is a device used in the bladder.
Seoul, Dongdaemun-guAges 19 years+ - NCT07500428Recruiting
Breast ultrasound AI study using existing images
This study uses existing breast ultrasound images to test how well artificial intelligence (AI) can interpret them. It may help improve future breast cancer detection tools.
BeijingAges 18–75 - NCT07504471RecruitingPhase 2
Bicarbonate plus chemo and immunotherapy for pancreatic cancer liver spread
This trial tests adding sodium bicarbonate to a chemotherapy plus immunotherapy regimen for pancreatic cancer that has spread to the liver. The goal is to see if this combination helps shrink tumors and improves outcomes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07504913Recruiting
Quality of life survey for stomach cancer patients after surgery
This study tests a new questionnaire to measure quality of life in people who had surgery to remove stomach cancer. If you had surgery for stomach cancer between 1 month and 5 years ago and are cancer-free now, your answers can help improve care.
Badalona, BarcelonaAges 18 years+ - NCT07505797Recruiting
Ultrasound imaging study for suspicious breast lesions
This study is testing a new ultrasound device (ATUSA) to see how well it can image breast lesions that have been classified as suspicious (BI-RADS 4 or 5). If you have a recent finding that needs further evaluation, this research might help improve detection methods.
Sacramento, CaliforniaAges 18–94 - NCT07509333Recruiting
Team-based treatment plan for older lung cancer patients
This trial is for older adults (60–90) with any stage of the two most common types of lung cancer (NSCLC or SCLC). It uses a team of experts to create a personalized treatment plan and closely monitors your health and quality of life.
Chengdu, SichuanAges 60–70 - NCT07517393Recruiting
Creating a Digital Lung Model Using AI and CT Scans
This study collects information from your chest CT scans and medical history to build an artificial intelligence model of how your lungs work. This 'digital twin' may help doctors better understand and predict lung health in the future.
Peschiera del Garda, VeronaAges 18 years+ - NCT07519811Recruiting
Plain-Language Summaries for Blood and Cancer Patient Letters
This study tests whether simplified, easy-to-read versions of your hospital discharge letters help you better understand your diagnosis and treatment plan. Researchers will ask you questions about the letter to see if the plain-language version works better than the standard medical version.
Munich, BavariaAges 18 years+ - NCT07523555RecruitingPhase 1/Phase 2
Dual-Target CAR-T Cells for Blood Cancers That Haven't Responded to Treatment
This study tests a new type of cell therapy called CAR-T cells that are designed to target two different proteins on cancer cells. These cells are made from your own immune cells, trained in the lab, and then put back into your body to fight blood cancers that have come back or stopped responding to previous treatments.
Shenzhen, GuangdongAges 18–75 - NCT07524062Recruiting
Thermal Imaging to Predict Surgical Wound Healing
This study uses thermal imaging (a camera that detects heat patterns on skin) to predict how well skin wounds will heal after surgery to remove suspicious or cancerous skin lesions. The goal is to identify which patients might have healing problems early so doctors can provide extra care.
Leuven, Vlaams BrabantAges 18 years+ - NCT07529782RecruitingPhase 1
Safety and Efficacy of HDP-101 in Relapsed or Refractory Multiple Myeloma
This trial tests a new drug called HDP-101 in patients with multiple myeloma that has come back or stopped responding to previous treatments. The study aims to find the safest and most effective dose and to see if this drug can help control the cancer.
Beijing, Beijing MunicipalityAges Up to 18 years - NCT07532824RecruitingPhase 1/Phase 2
Proton Radiation and Stem Cell Transplant for High-Risk Blood Cancers
This trial tests a new type of radiation therapy (proton-based) combined with a stem cell transplant from a donor to treat advanced forms of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The goal is to improve survival in patients with aggressive or hard-to-treat disease.
PragueAges 18–65 - NCT07542925Recruiting
Predicting ICU Needs After Cancer Surgery
This study helps doctors predict which cancer surgery patients will need intensive care after their operation. By understanding these patterns better, hospitals can prepare resources and plan better care for patients like you.
AnkaraAges 18 years+ - NCT07551440Recruiting
Finding treatment targets in advanced gastric cancer
This study looks for specific genetic or molecular markers in advanced gastric cancer that has spread to other parts of the body. The goal is to identify which treatments might work best for each patient's individual cancer.
Hong KongAges 18–80
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neoplasms?
- Yes. Clin2 currently lists 1,691 recruiting neoplasms studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neoplasms trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neoplasms trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.